[Should adjuvant chemotherapy be also used in Dukes stage B2 colon cancer?].
Porschen
R
R
Medizinische Klinik/Gastroenterologie, Abteilung Innere Medizin, Tübingen.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D003131:Combined Modality Therapy; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage / Q000009:adverse effects; D009367:Neoplasm Staging; D015996:Survival Rate; D016896:Treatment Outcome
D002955:Leucovorin; D005472:Fluorouracil
Soll eine adjuvante Chemotherapie auch schon im Stadium Dukes' B2 des Kolonkarzinoms eingesetzt werden?